menu
    • menu

    Company profile for Incyte Corporation

    NEW Drugs in Dev: 68
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Incyte's vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology. The field of oncology is evolving rapidly and transforming how cancer is and will be treated. With a growing pipeline that includes innovative compounds in three major oncology areas -- onco-inflammation, immuno-oncology and targeted...
    Incyte's vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology. The field of oncology is evolving rapidly and transforming how cancer is and will be treated. With a growing pipeline that includes innovative compounds in three major oncology areas -- onco-inflammation, immuno-oncology and targeted therapies -- we believe Incyte is at the center of this transformation in cancer care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Incyte CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1801 Augustine Cut-off Wilmington, DE 19803
    Telephone
    Telephone
    +1 1.855.446.2983
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.incyte.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Incyte to Present at Goldman Sachs Healthcare Conference
    Incyte to Present at Goldman Sachs Healthcare Conference

    26 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260526552507/en/Incyte-to-Present-at-the-Goldman-Sachs-47th-Annual-Global-Healthcare-Conference

    BUSINESSWIRE
    26 May 2026
    Share Share
    Lilly, BMS, Incyte Strike Deals to Keep AI Momentum Rolling
    Lilly, BMS, Incyte Strike Deals to Keep AI Momentum Rolling

    22 May 2026

    // BIOSPACE

    https://www.biospace.com/deals/lilly-bms-incyte-strike-deals-to-keep-biopharmas-ai-integration-rolling

    BIOSPACE
    22 May 2026
    Share Share
    Incyte, Genesis Expand Molecular AI For Drug Discovery
    Incyte, Genesis Expand Molecular AI For Drug Discovery

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260520680248/en/Incyte-and-Genesis-Expand-Molecular-AI-Collaboration-to-Accelerate-Drug-Discovery

    BUSINESSWIRE
    21 May 2026
    Share Share
    Incyte Inks Deal with Edison Scientific for AI Drug Discovery
    Incyte Inks Deal with Edison Scientific for AI Drug Discovery

    19 May 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/incyte-inks-deal-edison-scientific-train-ai-through-drug-discovery

    FIERCE BIOTECH
    19 May 2026
    Share Share
    Incyte To Deploy Edison Scientific's AI Scientist Kosmos For R&D
    Incyte To Deploy Edison Scientific's AI Scientist Kosmos For R&D

    19 May 2026

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/incyte-to-deploy-edison-scientifics-ai-scientist-kosmos-for-rd/

    CONTRACTPHARMA
    19 May 2026
    Share Share
    Incyte Reports 24-Week Opzelura Ph 3 Data for Atopic Dermatitis
    Incyte Reports 24-Week Opzelura Ph 3 Data for Atopic Dermatitis

    07 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260507606978/en/Incyte-Announces-24-Week-Long-Term-Data-from-Phase-3-TRuE-AD4-Trial-of-Opzelura-ruxolitinib-Cream-in-Adults-with-Moderate-Atopic-Dermatitis

    BUSINESSWIRE
    07 May 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search